Logo image of OMCL

OMNICELL INC (OMCL) Stock Fundamental Analysis

NASDAQ:OMCL - US68213N1090 - Common Stock

32.99 USD
-0.24 (-0.72%)
Last: 8/28/2025, 10:13:30 AM
Fundamental Rating

4

OMCL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. OMCL has only an average score on both its financial health and profitability. OMCL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year OMCL was profitable.
OMCL had a positive operating cash flow in the past year.
OMCL had positive earnings in 4 of the past 5 years.
OMCL had a positive operating cash flow in each of the past 5 years.
OMCL Yearly Net Income VS EBIT VS OCF VS FCFOMCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

With a decent Return On Assets value of 1.08%, OMCL is doing good in the industry, outperforming 72.97% of the companies in the same industry.
OMCL's Return On Equity of 1.83% is fine compared to the rest of the industry. OMCL outperforms 74.59% of its industry peers.
The Return On Invested Capital of OMCL (0.89%) is better than 66.49% of its industry peers.
Industry RankSector Rank
ROA 1.08%
ROE 1.83%
ROIC 0.89%
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
OMCL Yearly ROA, ROE, ROICOMCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

Looking at the Profit Margin, with a value of 2.01%, OMCL is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
In the last couple of years the Profit Margin of OMCL has declined.
OMCL has a better Operating Margin (1.52%) than 65.41% of its industry peers.
In the last couple of years the Operating Margin of OMCL has declined.
Looking at the Gross Margin, with a value of 43.88%, OMCL is doing worse than 63.24% of the companies in the same industry.
In the last couple of years the Gross Margin of OMCL has declined.
Industry RankSector Rank
OM 1.52%
PM (TTM) 2.01%
GM 43.88%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
OMCL Yearly Profit, Operating, Gross MarginsOMCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OMCL is destroying value.
The number of shares outstanding for OMCL has been increased compared to 1 year ago.
Compared to 5 years ago, OMCL has more shares outstanding
Compared to 1 year ago, OMCL has an improved debt to assets ratio.
OMCL Yearly Shares OutstandingOMCL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
OMCL Yearly Total Debt VS Total AssetsOMCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.99 indicates that OMCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
OMCL has a Altman-Z score of 1.99. This is in the better half of the industry: OMCL outperforms 61.08% of its industry peers.
OMCL has a debt to FCF ratio of 3.83. This is a good value and a sign of high solvency as OMCL would need 3.83 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.83, OMCL belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
A Debt/Equity ratio of 0.13 indicates that OMCL is not too dependend on debt financing.
OMCL's Debt to Equity ratio of 0.13 is in line compared to the rest of the industry. OMCL outperforms 57.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 3.83
Altman-Z 1.99
ROIC/WACC0.13
WACC6.92%
OMCL Yearly LT Debt VS Equity VS FCFOMCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

OMCL has a Current Ratio of 1.42. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
OMCL's Current ratio of 1.42 is on the low side compared to the rest of the industry. OMCL is outperformed by 76.22% of its industry peers.
OMCL has a Quick Ratio of 1.24. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
OMCL's Quick ratio of 1.24 is on the low side compared to the rest of the industry. OMCL is outperformed by 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.24
OMCL Yearly Current Assets VS Current LiabilitesOMCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.50% over the past year.
The Earnings Per Share has been decreasing by -9.56% on average over the past years.
Looking at the last year, OMCL shows a small growth in Revenue. The Revenue has grown by 6.39% in the last year.
OMCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.40% yearly.
EPS 1Y (TTM)25.5%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%-11.76%
Revenue 1Y (TTM)6.39%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%4.98%

3.2 Future

The Earnings Per Share is expected to grow by 6.56% on average over the next years.
Based on estimates for the next years, OMCL will show a small growth in Revenue. The Revenue will grow by 3.77% on average per year.
EPS Next Y-7%
EPS Next 2Y0.31%
EPS Next 3Y6.56%
EPS Next 5YN/A
Revenue Next Year3.99%
Revenue Next 2Y3.83%
Revenue Next 3Y4.12%
Revenue Next 5Y3.77%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
OMCL Yearly Revenue VS EstimatesOMCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
OMCL Yearly EPS VS EstimatesOMCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.64 indicates a rather expensive valuation of OMCL.
81.62% of the companies in the same industry are more expensive than OMCL, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.14, OMCL is valued a bit cheaper.
With a Price/Forward Earnings ratio of 19.28, OMCL is valued on the expensive side.
OMCL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. OMCL is cheaper than 79.46% of the companies in the same industry.
OMCL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 17.64
Fwd PE 19.28
OMCL Price Earnings VS Forward Price EarningsOMCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OMCL is valued cheaper than 83.24% of the companies in the same industry.
OMCL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OMCL is cheaper than 90.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.99
EV/EBITDA 13.53
OMCL Per share dataOMCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.31%
EPS Next 3Y6.56%

0

5. Dividend

5.1 Amount

No dividends for OMCL!.
Industry RankSector Rank
Dividend Yield N/A

OMNICELL INC

NASDAQ:OMCL (8/28/2025, 10:13:30 AM)

32.99

-0.24 (-0.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners103.41%
Inst Owner Change3.35%
Ins Owners1.78%
Ins Owner Change28.51%
Market Cap1.52B
Analysts77.14
Price Target44.88 (36.04%)
Short Float %4.44%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.47%
Min EPS beat(2)24.34%
Max EPS beat(2)68.6%
EPS beat(4)4
Avg EPS beat(4)32.49%
Min EPS beat(4)1.42%
Max EPS beat(4)68.6%
EPS beat(8)8
Avg EPS beat(8)81.06%
EPS beat(12)12
Avg EPS beat(12)121.92%
EPS beat(16)14
Avg EPS beat(16)93.28%
Revenue beat(2)2
Avg Revenue beat(2)2.64%
Min Revenue beat(2)1.68%
Max Revenue beat(2)3.59%
Revenue beat(4)3
Avg Revenue beat(4)1.11%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)3.59%
Revenue beat(8)5
Avg Revenue beat(8)1.39%
Revenue beat(12)8
Avg Revenue beat(12)1.02%
Revenue beat(16)9
Avg Revenue beat(16)0.47%
PT rev (1m)-1.12%
PT rev (3m)-16.98%
EPS NQ rev (1m)4.76%
EPS NQ rev (3m)-29.92%
EPS NY rev (1m)18.84%
EPS NY rev (3m)13.49%
Revenue NQ rev (1m)4.06%
Revenue NQ rev (3m)2.96%
Revenue NY rev (1m)1.47%
Revenue NY rev (3m)1.47%
Valuation
Industry RankSector Rank
PE 17.64
Fwd PE 19.28
P/S 1.32
P/FCF 16.99
P/OCF 10.26
P/B 1.2
P/tB 5.2
EV/EBITDA 13.53
EPS(TTM)1.87
EY5.67%
EPS(NY)1.71
Fwd EY5.19%
FCF(TTM)1.94
FCFY5.89%
OCF(TTM)3.22
OCFY9.75%
SpS25.03
BVpS27.51
TBVpS6.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.08%
ROE 1.83%
ROCE 1.13%
ROIC 0.89%
ROICexc 1.22%
ROICexgc 8.95%
OM 1.52%
PM (TTM) 2.01%
GM 43.88%
FCFM 7.76%
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-30.61%
ROICexc growth 3Y-63.57%
ROICexc growth 5Y-44.11%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 3.83
Debt/EBITDA 1.59
Cap/Depr 67.12%
Cap/Sales 5.09%
Interest Coverage 250
Cash Conversion 141.11%
Profit Quality 386.27%
Current Ratio 1.42
Quick Ratio 1.24
Altman-Z 1.99
F-Score7
WACC6.92%
ROIC/WACC0.13
Cap/Depr(3y)62.08%
Cap/Depr(5y)71.19%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.5%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%-11.76%
EPS Next Y-7%
EPS Next 2Y0.31%
EPS Next 3Y6.56%
EPS Next 5YN/A
Revenue 1Y (TTM)6.39%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%4.98%
Revenue Next Year3.99%
Revenue Next 2Y3.83%
Revenue Next 3Y4.12%
Revenue Next 5Y3.77%
EBIT growth 1Y168.06%
EBIT growth 3Y-60.85%
EBIT growth 5Y-41.24%
EBIT Next Year87.65%
EBIT Next 3Y30.41%
EBIT Next 5YN/A
FCF growth 1Y-30%
FCF growth 3Y-8.04%
FCF growth 5Y10.13%
OCF growth 1Y-21.83%
OCF growth 3Y-6.79%
OCF growth 5Y5.3%